BRIEF published on 12/17/2025 at 11:02, 3 months 21 days ago Valerio Therapeutics Welcomes Professor Eric Vivier to its Board of Directors Board Of Directors Oncology Immunology Valerio Therapeutics Eric Vivier
BRIEF published on 12/17/2025 at 11:02, 3 months 21 days ago Valerio Therapeutics Accueille le Professeur Eric Vivier au Conseil d'Administration Conseil D'administration Oncologie Valerio Therapeutics Immunologie Eric Vivier
BRIEF published on 12/17/2025 at 11:02, 3 months 21 days ago Valerio Therapeutics nomme le professeur Eric Vivier observateur au conseil d'administration Conseil D'administration Valerio Thérapeutique Immunologie Professeur Eric Vivier Stratégie En Oncologie
BRIEF published on 12/17/2025 at 11:02, 3 months 21 days ago Valerio Therapeutics Appoints Professor Eric Vivier as Board Observer Board Of Directors Immunology Valerio Therapeutics Professor Eric Vivier Oncology Strategy
PRESS RELEASE published on 12/17/2025 at 10:57, 3 months 21 days ago Informations privilégiées / Autres communiqués Valerio Therapeutics annonce la désignation du Professeur Eric Vivier en qualité d'Observateur de son Conseil d’Administration. Le Professeur apportera son expertise en immunologie pour développer des traitements innovants en oncologie Conseil D'administration Valerio Therapeutics Immunologie Professeur Eric Vivier Observateur
PRESS RELEASE published on 12/17/2025 at 10:57, 3 months 21 days ago Inside Information / Other news releases Valerio Therapeutics appoints Prof. Eric Vivier as Observer to Board of Directors. Prof. Vivier, a renowned immunologist, will bring over 30 years of experience to drive innovative tumor treatment approaches Board Of Directors Valerio Therapeutics Professor Eric Vivier Immunologist Tumor Treatment
PRESS RELEASE published on 10/30/2025 at 09:04, 5 months 8 days ago Rapport financier semestriel 2025
BRIEF published on 10/30/2025 at 09:03, 5 months 8 days ago Bilan financier et stratégique de Valerio Therapeutics pour le 1er semestre 2025 Recentrage Stratégique Valerio Therapeutics Résultats Financiers 2025 Plateformes V-Body Recherche Partenariats
BRIEF published on 10/30/2025 at 09:03, 5 months 8 days ago Valerio Therapeutics' financial and strategic review for the first half of 2025 Strategic Refocusing Valerio Therapeutics 2025 Financial Results V-Body Platforms Seeking Partnerships
Published on 04/07/2026 at 15:00, 3 hours 50 minutes ago Karbon-X Expands Enterprise Climate Platform Through Strategic Partnership with carbon-connect AG
Published on 04/07/2026 at 14:45, 4 hours 5 minutes ago Predictiv AI Introduces Clinical AI Reasoning Platform, Files Patent for Domain-Specific Clinical AI Methodology
Published on 04/07/2026 at 14:40, 4 hours 10 minutes ago bioEnergy Development Inc. Advances Domestic Activated Carbon Production Worth Up to $30 Million Over 5 Years
Published on 04/07/2026 at 14:30, 4 hours 20 minutes ago Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides
Published on 04/07/2026 at 14:30, 4 hours 20 minutes ago Sekur Private Data Announces Philip Oakley and Kenneth Rogers as Members of Strategic Advisory Board
Published on 04/07/2026 at 17:45, 1 hour 5 minutes ago VAZIVA SA: Mise à jour des modalités de l’émission d’obligations convertibles en actions nouvelles (OCA) de 8 M€ à un taux de 7,0% par an et à maturité de 3 ans
Published on 04/07/2026 at 17:45, 1 hour 5 minutes ago FIGEAC AÉRO: INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/07/2026 at 17:40, 1 hour 10 minutes ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 04/07/2026 at 16:32, 2 hours 18 minutes ago Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.
Published on 04/07/2026 at 16:30, 2 hours 20 minutes ago From Old Channel to New Garden: How Chaoyang’s 'Sakura River' is Dazzling Spring
Published on 04/07/2026 at 18:00, 50 minutes ago LDC : Chiffre d’affaires du 4 ème trimestre 2025-2026. Solide croissance du chiffre d’affaires au 4ème trimestre 2025-2026 et révision à la hausse des objectifs.
Published on 04/07/2026 at 17:57, 53 minutes ago Peugeot Invest publishes its 2025 Universal Registration Document
Published on 04/07/2026 at 17:57, 53 minutes ago Mise à disposition du Document d’enregistrement universel 2025
Published on 04/07/2026 at 17:45, 1 hour 5 minutes ago ENGIE accelerates the deployment of battery storage with nearly 400 MW of new projects in Europe
Published on 04/07/2026 at 17:45, 1 hour 5 minutes ago ENGIE accélère le déploiement du stockage par batteries avec près de 400 MW de nouveaux projets en Europe
